We Haven’t Discovered Another Planet,It Was Already Inhabited: (Re)considering Psychedelic-Assisted Therapy as Indigenously Informed Spiritual Care

Griffiths RR , Johnson MW , Carducci MA , et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol, 2016; 30(12):1181–1197; doi: 10.1177/0269881116675513

Ross S , Bossis A , Guss J , et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol, 2016; 30(12):1165–1180; doi: 10.1177/0269881116675512

Keighley EE , Abo Hamza E , Bedewy DA , et al. A systematic review and meta-analysis investigating the efficacy of various psychedelic drugs for the treatment of substance use disorder. Healthcare (Basel), 2025; 13(21):2668.

d’Andrea G , Chiappini S , Ciavoni L , et al. Psychedelics and ketamine/esketamine in depressive disorders: Biological mechanisms and associated neuroimaging and clinical changes. Transl Psychiatry, 2025; 15(1):453.

Dorczok MC , Mittmann G , Ettl T , et al. Psilocybin-assisted psychotherapy in adults with depression—A literature review. Prog Neuropsychopharmacol Biol Psychiatry, 2025; 142:111508.

Byock I . Taking psychedelics seriously. J Palliat Med, 2018; 21(4):417–421.

Beaussant Y , Sanders J , Sager Z , et al. Defining the roles and research priorities for psychedelic-assisted therapies in patients with serious illness: Expert clinicians’ and investigators’ perspectives. J Palliat Med, 2020; 23(10):1323–1334.

Alexander WB , Hansen ED , Anderson BT , et al. Meaning and psychedelics in palliative care: A narrative review. J Pain Symptom Manage, 2025; 29:S0885.

Cornish N , Coles T , Cheng MJ , et al. Psychedelics, spirituality, and existential distress in patients at the end of life. Cleve Clin J Med, 2025; 92(4):248–254.

Maia LO , Beaussant Y , Garcia ACM . The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: A systematic review. J Pain Symptom Manage, 2022; 63(6):e725–e738.

Agin-Liebes GI , Malone T , Yalch MM , et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol, 2020; 34(2):155–166.

Rosa WE , Sager Z , Miller M , et al. Top ten tips palliative care clinicians should know about psychedelic-assisted therapy in the context of serious illness. J Palliat Med, 2022; 25(8):1273–1281; doi: 10.1089/jpm.2022.0036

Blinderman CD . Psycho-existential distress in cancer patients: A return to “entheogens. J Psychopharmacol, 2016; 30(12):1205–1206.

Ko K , Knight G , Rucker JJ , et al. Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Front Psychiatry, 2022; 13:917199; doi: 10.3389/fpsyt.2022.917199

Pahnke WN . Drugs and Mysticism: An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness. A thesis presented to the Committee on Higher Degrees in History and Philosophy of Religion, Harvard University; 1963.

Wittgenstein L . Tractatus Logico-Philosophicus. ( Ogden CK ., Trans) Routledge & Kegan Paul: London; 1922; p. 89.

Bourzat F , Hunter K . Consciousness Medicine: Indigenous Wisdom, Entheogens, and Expanded States of Consciousness for Healing and Growth. Foreword by Metzner R. North Atlantic Books: Berkeley, CA; 2019.

University of Washington. A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients with Metastatic Cancer. ClinicalTrials.gov: Identifier: NCT05847686. Available from: https://clinicaltrials.gov/ct2/show/NCT05847686 [Last accessed: May 7, 2025].

Foucault M . The Birth of the Clinic: An Archaeology of Medical Perception. Vintage Books: New York, NY; 1994.

National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care, 4th ed. National Coalition for Hospice and Palliative Care: Richmond, VA; 2018. Available from: https://www.nationalcoalitionhpc.org/ncp

Siff S . R. Gordon Wasson and the publicity campaign to introduce magic mushrooms to mid-century America. Revue Française D’études Américaines, 2018; N° 156(3):91–104; doi: 10.3917/rfea.156.0091

Heinrich M , Fankhauser M . Mystic Chemist: The Life of Albert Hofmann and His Discovery of LSD. Synergetic Press: Santa Fe, NM; 2013.

Gerber K , Flores IG , Ruiz AC , et al. Ethical Concerns about Psilocybin Intellectual Property. ACS Pharmacol Transl Sci, 2021; 4(2):573–577.

Celidwen Y , Redvers N , Githaiga C , et al. Ethical principles of traditional Indigenous medicine to guide western psychedelic research and practice. Lancet Reg Health Am, 2023; 18:100410; doi: 10.1016/j.lana.2022.100410

World Bank. Available from: https://www.worldbank.org/en/topic/indigenouspeoples [Last accessed: November 16, 2025].

Global ayahuasca trend drives deforestation in Brazil’s Acre state. Mongabay Environmental News; 2021. Available from: https://news.mongabay.com/2021/12/global-ayahuasca-trend-drives-deforestation-in-brazils-acre-state/ [Last accessed: November 16, 2025].

George JR , Michaels TI , Sevelius J , et al. The Psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. J Psychedelic Stud, 2019; 4(1):4–15.

Michaels TI , Purdon J , Collins A , et al. Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry, 2018; 18(1):245. https://doi.org/10.1186/s12888-018-1824-6